Holzgartner H, Maier E, Vierling W
Institut für Pharmakologie und Toxikologie, Technischen Universität München.
Fortschr Med. 1990 Sep 30;108(28):539-42.
In the treatment of cardiac arrhythmias of varying genesis, an "observational study" in 1,160 patients showed that a high-dose oral magnesium preparation (Magnesium-Diasporal N 300 Granulat) was effective. In 82% of the patients observed, a dose of at least 300 mg magnesium/day produced good to very good results. Adverse effects of the drug were observed in only 1.6% of the patients. For all groups, the "success parameters" improved significantly. High-rate arrhythmias showed a better response to magnesium treatment than did low-rate arrhythmias, with a close correlation being found with the heart rate at the start of treatment. High-dose oral magnesium had a positive effect on concomitant hypertension. At a dosage of 300 mg treatment should be continued for at least 6 weeks.
在对不同病因的心律失常进行治疗时,一项针对1160名患者的“观察性研究”表明,高剂量口服镁制剂(镁泻盐N 300颗粒)是有效的。在观察的患者中,82%的患者每天服用至少300毫克镁产生了良好到非常好的效果。仅1.6%的患者观察到该药物的不良反应。对于所有组,“成功参数”均有显著改善。高心率心律失常对镁治疗的反应比低心率心律失常更好,且与治疗开始时的心率密切相关。高剂量口服镁对伴发的高血压有积极作用。剂量为300毫克时,治疗应持续至少6周。